Ca2+ Signaling, ICAM-1 Expression, and Lung Vascular Injury

Ca2 信号传导、ICAM-1 表达和肺血管损伤

基本信息

项目摘要

Thrombin-induced endothelial cell surface ICAM-1 expression plays a critical role in the pathogenesis of lung vascular injury. Signaling via the transcription factor NF-kappaB is required for the stable thrombin-induced ICAM-1 expression in endothelial cells. In Project 3, we will address the role of thrombin-induced Ca2" entry in the mechanism of NF-KB activation and signaling ICAM-1 expression and neutrophil (PMN) adhesion-mediated lung vascular injury. Our studies indicate that the thrombin-induced increase in intracellular Ca2+ concentration is dependent on both Ca2+ store depletion and the Ca2+ store depletion-mediated Ca2+ influx. Further, we have shown that thrombin-induced Ca2+ influx occurs via transient receptor potential channels (TRPCs) expressed in endothelial cells. TRPC4 gene deletion (TRPC4-/-) in mice prevented thrombin-induced Ca2+ influx. In Supporting Data, we show using pharmacological and gene knockout approaches that the thrombin-induced Ca2+ influx is critically involved in signaling NF-kappaB activation and ICAM-1 expression in lung endothelial cells. Moreover, inhibition of Ca2+-dependent PKC-alpha markedly reduced the thrombin-induced ICAM-1 expression. However, the inhibition of calcineurin (Ca2+/ calmodulin-dependent phosphatase) increased thrombin-induced ICAM-1 expression in pulmonary endothelial cells. Based on these preliminary results, in Aim 1, we will test the hypothesis that TRPC-mediated Ca2+ influx regulates NF-kappaB activation, ICAM-1 expression, and PMN adhesion to pulmonary vascular endothelial cells. In Aim 2, we will test the hypothesis that the Ca2+ activation of PKC-alpha is required for ICAM-1 gene transcription via NF-kappaB activation. In Aim 3, we will test the hypothesis that thrombin-induced calcineurin activation acts in a negative feedback manner to inhibit ICAM-1 gene expression by preventing NF-kappaB activation. In Aim 4 studies, we will test the hypothesis that NF-kappaB activated TRPC1 expression augments Ca2+ influx, and the resultant ICAM-1 expression and PMN adhesion to pulmonary vascular endothelial cells. Studies will be carried out using endothelial cell culture, genetically modified mice (e.g., TRPC4-/- mice), and intact lungs. With these studies, we will be able to provide novel insights into the role of Ca2+ influx in endothelial cells in the mechanism of lung vascular injury and tissue inflammation.
凝血酶诱导的内皮细胞表面ICAM-1的表达在肺血管损伤的发病机制中起关键作用。通过转录因子NF-κ B的信号传导是凝血酶诱导的内皮细胞中ICAM-1稳定表达所必需的。在项目3中,我们将讨论凝血酶诱导的Ca 2+内流在NF-κ B活化机制中的作用, 信号传导ICAM-1表达和中性粒细胞(PMN)粘附介导的肺血管损伤。我们的研究表明,凝血酶诱导的细胞内Ca ~(2+)浓度增加依赖于Ca ~(2+)库耗竭和Ca ~(2+)库耗竭介导的Ca ~(2+)内流。此外,我们已经表明凝血酶诱导的Ca 2+内流通过瞬时受体发生, 潜在通道(TRPC)在内皮细胞中表达。TRPC 4基因缺失(TRPC 4-/-)可抑制凝血酶诱导的Ca 2+内流。在支持性数据中,我们使用药理学和基因敲除方法表明凝血酶诱导的Ca 2+内流在肺内皮细胞中的NF-κ B活化和ICAM-1表达的信号转导中起关键作用。此外,抑制Ca 2+依赖性PKC-α显著降低凝血酶诱导的ICAM-1表达。然而,钙调磷酸酶(钙/钙调素依赖性磷酸酶)的抑制增加凝血酶诱导的肺内皮细胞ICAM-1的表达。基于这些初步结果,在目标1中,我们将检验TRPC介导的 Ca 2+内流调节NF-κ B活化、ICAM-1表达和PMN与肺血管内皮细胞的粘附在目的2中,我们将检验这样的假设,即PKC-α的Ca 2+激活是ICAM-1基因通过NF-κ B激活而转录所必需的。在目标3中,我们将检验凝血酶诱导的钙调神经磷酸酶激活在负反馈中起作用的假设 通过阻止NF-κ B活化来抑制ICAM-1基因表达的方式。在目的4的研究中,我们将测试的假设,NF-κ B激活TRPC 1的表达增加Ca 2+内流,和由此产生的ICAM-1的表达和PMN粘附到肺血管内皮细胞。研究将使用内皮细胞培养物、遗传修饰的小鼠(例如,TRPC 4-/-小鼠)和完整肺。通过这些研究,我们将能够提供新的见解,在肺血管损伤和组织炎症的机制中,内皮细胞中的Ca 2+内流的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHINNASWAMY TIRUPPATHI其他文献

CHINNASWAMY TIRUPPATHI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHINNASWAMY TIRUPPATHI', 18)}}的其他基金

Novel E3 Ubiquitin Ligase CHFR Regulates Endothelial Barrier Integrity and Innate Immune Function
新型 E3 泛素连接酶 CHFR 调节内皮屏障完整性和先天免疫功能
  • 批准号:
    10488226
  • 财政年份:
    2021
  • 资助金额:
    $ 28.28万
  • 项目类别:
Transcription Factor Elf2 Signals Resolution of Lung Injury
转录因子 Elf2 发出肺损伤消退信号
  • 批准号:
    10363718
  • 财政年份:
    2021
  • 资助金额:
    $ 28.28万
  • 项目类别:
Novel E3 Ubiquitin Ligase CHFR Regulates Endothelial Barrier Integrity and Innate Immune Function
新型 E3 泛素连接酶 CHFR 调节内皮屏障完整性和先天免疫功能
  • 批准号:
    10297258
  • 财政年份:
    2021
  • 资助金额:
    $ 28.28万
  • 项目类别:
Transcription Factor Elf2 Signals Resolution of Lung Injury
转录因子 Elf2 发出肺损伤消退信号
  • 批准号:
    10178835
  • 财政年份:
    2021
  • 资助金额:
    $ 28.28万
  • 项目类别:
Transcription Factor Elf2 Signals Resolution of Lung Injury
转录因子 Elf2 发出肺损伤消退信号
  • 批准号:
    10586059
  • 财政年份:
    2021
  • 资助金额:
    $ 28.28万
  • 项目类别:
Endothelial TAK1 Signaling and Resolution of Pulmonary Edema in Sepsis
脓毒症肺水肿的内皮 TAK1 信号转导和解决
  • 批准号:
    9535680
  • 财政年份:
    2016
  • 资助金额:
    $ 28.28万
  • 项目类别:
Endothelial Cell Deubiquitinase A20 Signals Repair of Lung Vascular Injury
内皮细胞去泛素酶 A20 发出肺血管损伤修复信号
  • 批准号:
    9301023
  • 财政年份:
    2015
  • 资助金额:
    $ 28.28万
  • 项目类别:
TRPM2 mediates neutrophil transendothelial migration and inflammation
TRPM2介导中性粒细胞跨内皮迁移和炎症
  • 批准号:
    9260918
  • 财政年份:
    2015
  • 资助金额:
    $ 28.28万
  • 项目类别:
Endothelial Cell Deubiquitinase A20 Signals Repair of Lung Vascular Injury
内皮细胞去泛素酶 A20 发出肺血管损伤修复信号
  • 批准号:
    9105412
  • 财政年份:
    2015
  • 资助金额:
    $ 28.28万
  • 项目类别:
Cell Culture and Vector Core
细胞培养和载体核心
  • 批准号:
    7457951
  • 财政年份:
    2007
  • 资助金额:
    $ 28.28万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.28万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.28万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.28万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 28.28万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 28.28万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 28.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了